北京市心肺血管疾病研究所

您所在的位置: 首页 >>科研团队 >>科研团队 >>流行病研究室 > 正文

科研团队

流行病研究室

赵 冬 教授

浏览次数:
字号:
+-14

图片2.jpg

研究方向:心血管病流行病学 

个人简介:

首都医科大学附属北京安贞医院-北京心肺血管疾病研究所副所长、流行病研究室主任、首都医科大学博士生导师

卫生部疾病控制专家委员会委员,国家心血管病专家委员会委员, 中华预防学会慢性病分会副主任委员、中华医学会心血管病分会委员、中国医师协会心血管分会委员。 中国高血压联盟理事, 北京高血压防治协会副会长。 

现任国际动脉粥样硬化协会执行委员会委员,世界心脏联盟科学和政策专家委员会委员. ,美国心脏病协会2011年-2014年学术年会科学委员会国际委员。 亚太区心血管病协会预防分会副主席。国际多部指南编写委员会成员。Nature Review Cardiology 杂志专家委会成员。中华心血管病杂志编委、中华流行病学杂志编委、中华内科杂志编委、中华预防与疾病控制杂志编委, 近20年来,在国内外专业杂志发表中英文论文二百余篇,参编论著4本。2012年获教育部科技进步一等奖,2013年获中华医学三等奖。曾获卫生部科技进步二等奖,北京市科技进步二等奖、卫生部科技进步三等奖。 

近五年发表SCI文章:

Zhao D, Liu J. The burden of cardiovascular disease and its impact on life expectancy in China. Eur Heart J. 2014;35(38):2625-6.

Wang M, Moran AE, Liu J, Coxson PG, Heidenreich PA, Gu D, He J, Goldman L, Zhao D. Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China. Circ Cardiovasc Qual Outcomes. 2014;7(1):78-85.

Wang Y, Liu J, Wang W, Wang M, Qi Y, Xie W, Li Y, Sun J, Liu J, Zhao D. Lifetime risk for cardiovascular disease in a Chinese population: the Chinese Multi-Provincial Cohort Study. Eur J Prev Cardiol. 2015;22(3):380-8.  

Grundy SM, Arai H, Barter P, Bersot TP, Betteridge DJ, Carmena R, Cuevas A, Davidson MH, Genest J, Kesäniemi YA, Sadikot S, Santos RD,Susekov A, Sy R, Tokgozoglu SL, Watts GF, Zhao D. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia. J Clin Lipidol. 2013;7(6):561-5. 

Bonita R, Magnusson R, Bovet P, Zhao D, Malta DC, Geneau R, Suh I, Thankappan KR, McKee M,Hospedales J, de Courten M, Capewell S, Beaglehole R; Lancet NCD Action Group. Country actions to meet UN commitments on non-communicable diseases: a stepwise approach. Lancet. 2013;381(9866):575-84.

Cheng TO, Zhao D. Current practice on the management of acute coronary syndrome in China. Int J Cardiol. 2013;169(1):1-6.

Zhao D, Hu D. Barriers to translating EU and US CVD guidelines into practice in China. Nat Rev Cardiol. 2012;9(7):425-9.

Qi Y, Liu J, Ma C, Wang W, Liu X, Wang M, Lv Q, Sun J, Liu J, Li Y, Zhao D. Association between cholesterol synthesis/absorption markers and effects of cholesterol   lowering by atorvastatin among patients with high risk of coronary heart disease. J Lipid Res. 2013;54(11):3189-97.

Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, Liu J, Cheng J, Bibbins-Domingo K, Shen YM, He J, Goldman L. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes. 2010;3(3):243-52.

Moran AE, Oliver JT, Mirzaie M, Forouzanfar MH, Chilov M, Anderson L, Morrison JL, Khan A, Zhang N,Haynes N, Tran J, Murphy A, Degennaro V, Roth G, Zhao D, Peer N, Pichon-Riviere A, Rubinstein A,Pogosova N, Prabhakaran D, Naghavi M, Ezzati M, Mensah GA. Assessing the Global Burden of Ischemic Heart Disease: Part 1: Methods for a Systematic Review of the Global Epidemiology of Ischemic Heart Disease in 1990 and 2010. Glob Heart. 2012;7(4):315-329.

Li Y, Liu J, Wang W, Yong Q, Zhou G, Wang M, Sun J, Zhao D. Association of self-reported snoring with carotid artery intima-media thickness and plaque. J Sleep Res. 2012;21(1):87-93.

Zhao D, Zhao F, Li Y, Zheng Z. Projected and observed diabetes epidemics in China and beyond. Curr Cardiol Rep. 2012;14(1):106-11. 

Liu J, Wang W, Wang M, Sun J, Liu J, Li Y, Qi Y, Wu Z, Zhao D. Impact of diabetes, high triglycerides and low HDL cholesterol on risk for ischemic cardiovascular disease varies by LDL cholesterol level: A 15-year follow-up of the Chinese Multi-provincial Cohort Study. Diabetes Res Clin Pract. 2012;96(2):217-24.

Zhao D, Qi Y, Zheng Z, Wang Y, Zhang XY, Li HJ, Liu HH, Zhang XT, Du J, Liu J. Dietary factors associated with hypertension. Nat Rev Cardiol. 2011;8(8):456-65.

Wang N, Zhao D, Liu J, Yu CM, Wang W, Sun J, Li Y, Du F; BRIG project. Impact of heart failure on in-hospital outcomes of acute coronary syndrome patients in China- Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) project. Int J Cardiol. 2012;160(1):15-9.

Qi Y, Liu J, Wang W, Wang M, Sun JY, Liu J, Li Y, Wu ZS, Zhao D. The HindIII polymorphism in the lipoprotein lipase gene predicts type 2 diabetes risk among Chinese adults. Clin Chim Acta. 2011;412(13-14):1229-33.

Ren J, Grundy SM, Liu J, Wang W, Wang M, Sun J, Liu J, Li Y, Wu Z, Zhao D. Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: the results of a 15-Year Chinese Multi-Provincial Cohort Study (CMCS). Atherosclerosis. 2010;211(1):327-32.

Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, Liu J, Cheng J, Bibbins-Domingo K, Shen YM, He J, Goldman L. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes. 2010;3(3):243-52.

Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Piña IL, Roger VL,Shaw LJ, Zhao D, Beckie TM, Bushnell C, D'Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS,Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E,Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC Jr, Sopko G, Chandra-Strobos N, Urbina EM, Vaccarino V,Wenger NK. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation. 2011;123(11):1243-62.

Huffman MD, Rao KD, Pichon-Riviere A, Zhao D, Harikrishnan S, Ramaiya K, Ajay VS, Goenka S,Calcagno JI, Caporale JE, Niu S, Li Y, Liu J, Thankappan KR, Daivadanam M, van Esch J, Murphy A, Moran AE, Gaziano TA, Suhrcke M, Reddy KS, Leeder S, Prabhakaran D. A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries. PLoS One. 2011;6(6):e20821.

联系方式:E-mail:deezhao@vip.sina.com

电话:010-64456524